Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Protean Agonism at the Dopamine D2 Receptor: (S)-3-(3-Hydroxyphenyl)-N-propylpiperidine Is an Agonist for Activation of Go1 but an Antagonist/Inverse Agonist for Gi1,Gi2, and Gi3

J. Robert Lane, Ben Powney, Alan Wise, Steven Rees and Graeme Milligan
Molecular Pharmacology May 2007, 71 (5) 1349-1359; DOI: https://doi.org/10.1124/mol.106.032722
J. Robert Lane
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ben Powney
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alan Wise
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steven Rees
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Graeme Milligan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 71 no. 5 1349-1359
DOI 
https://doi.org/10.1124/mol.106.032722
PubMed 
17287401

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Received November 15, 2006
  • Accepted February 7, 2007
  • Published online April 25, 2007.

Article Versions

  • Earlier version (February 7, 2007 - 10:36).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. J. Robert Lane,
  2. Ben Powney,
  3. Alan Wise,
  4. Steven Rees and
  5. Graeme Milligan
  1. Molecular Pharmacology Group, Division of Biochemistry and Molecular Biology, Institute of Biomedical and Life Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom (J.R.L., G.M.); and Screening & Compound Profiling, GlaxoSmithKline Research & Development, Harlow, Essex, United Kingdom (A.W., S.R., B.P.)
  1. Address correspondence to:
    Dr. G. Milligan, Davidson Building, University of Glasgow, Glasgow G12 8QQ, Scotland, U.K. E-mail: g.milligan{at}bio.gla.ac.uk
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: February 2007 to September 2023

AbstractFullPdf
Feb 2007680183
Mar 2007420122
Apr 200710917108
May 2007316385
Jun 2007155564
Jul 200791837
Aug 2007103027
Sep 200781821
Oct 2007121522
Nov 2007201724
Dec 2007111528
Jan 200881912
Feb 2008121317
Mar 2008151714
Apr 2008301718
May 2008272733
Jun 2008174613
Jul 2008182126
Aug 2008154513
Sep 2008192713
Oct 2008243025
Nov 2008221616
Dec 20085297
Jan 2009111913
Feb 20097209
Mar 2009321612
Apr 2009131213
May 2009172421
Jun 2009101513
Jul 2009162212
Aug 200911145
Sep 2009889
Oct 200961111
Nov 20091994
Dec 20093754
Jan 201029157
Feb 201028189
Mar 2010151543
Apr 2010141510
May 20109157
Jun 201014913
Jul 2010131111
Aug 201018512
Sep 201018610
Oct 201012811
Nov 2010111012
Dec 201012713
Jan 2011181214
Feb 2011131014
Mar 2011131721
Apr 20118118
May 201191211
Jun 201191015
Jul 201114314
Aug 2011151414
Sep 2011141218
Oct 2011121410
Nov 2011232513
Dec 2011122317
Jan 2012101115
Feb 2012111015
Mar 201271417
Apr 201210715
May 201291625
Jun 201281220
Jul 2012102317
Aug 2012221924
Sep 2012879
Oct 201221811
Nov 2012171819
Dec 20121079
Jan 2013282414
Feb 201310612
Mar 201313812
Apr 201316910
May 2013231117
Jun 2013445
Jul 2013454
Aug 20132310
Sep 20131439
Oct 20131547
Nov 2013845
Dec 2013923
Jan 201412310
Feb 20148712
Mar 2014167
Apr 2014963
May 2014816
Jun 20141175
Jul 201471210
Aug 2014772
Sep 2014452
Oct 201418157
Nov 20142457
Dec 20141032
Jan 20151256
Feb 2015645
Mar 20151336
Apr 20151251
May 20152347
Jun 20152084
Jul 2015242410
Aug 201531115
Sep 20151033
Oct 2015203
Nov 2015554
Dec 2015932
Jan 201613810
Feb 2016191011
Mar 2016171619
Apr 2016648
May 201611512
Jun 2016354
Jul 20166106
Aug 20168133
Sep 20163102
Oct 20169194
Nov 20169145
Dec 20164155
Jan 20172184
Feb 20170163
Mar 20173200
Apr 20170182
May 20170277
Jun 20171135
Jul 20170199
Aug 20173205
Sep 20170193
Oct 20171173
Nov 20171313
Dec 20170196
Jan 201842213
Feb 20180194
Mar 20181222
Apr 20181344
May 20182374
Jun 20180247
Jul 20182163
Aug 20180788
Sep 201803714
Oct 20182399
Nov 20180703
Dec 20184895
Jan 20196023
Feb 20195711
Mar 20193124
Apr 2019401
May 20191401
Jun 2019917
Jul 20191077
Aug 201927516
Sep 201920521
Oct 2019921
Nov 20191432
Dec 20192151
Jan 20201300
Feb 20201410
Mar 20201011
Apr 20201711
May 2020410
Jun 2020712
Jul 2020800
Aug 2020812
Sep 2020622
Oct 20201401
Nov 2020512
Dec 20201057
Jan 202120145
Feb 202114123
Mar 202139102
Apr 20213830
May 20211383
Jun 20212354
Jul 20211814
Aug 20211184
Sep 20212121
Oct 20211464
Nov 2021913
Dec 20212941
Jan 20222611
Feb 2022911
Mar 2022633
Apr 20222432
May 2022510
Jun 20221411
Jul 20222412
Aug 2022913
Sep 20221421
Oct 20222271
Nov 20221013
Dec 2022442
Jan 20231171
Feb 2023520
Mar 20231150
Apr 20231021
May 2023312
Jun 2023732
Jul 20232052
Aug 20232023
Sep 2023850

PreviousNext
Back to top

In this issue

Molecular Pharmacology: 71 (5)
Molecular Pharmacology
Vol. 71, Issue 5
1 May 2007
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Protean Agonism at the Dopamine D2 Receptor: (S)-3-(3-Hydroxyphenyl)-N-propylpiperidine Is an Agonist for Activation of Go1 but an Antagonist/Inverse Agonist for Gi1,Gi2, and Gi3
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Protean Agonism at the Dopamine D2 Receptor: (S)-3-(3-Hydroxyphenyl)-N-propylpiperidine Is an Agonist for Activation of Go1 but an Antagonist/Inverse Agonist for Gi1,Gi2, and Gi3

J. Robert Lane, Ben Powney, Alan Wise, Steven Rees and Graeme Milligan
Molecular Pharmacology May 1, 2007, 71 (5) 1349-1359; DOI: https://doi.org/10.1124/mol.106.032722

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Protean Agonism at the Dopamine D2 Receptor: (S)-3-(3-Hydroxyphenyl)-N-propylpiperidine Is an Agonist for Activation of Go1 but an Antagonist/Inverse Agonist for Gi1,Gi2, and Gi3

J. Robert Lane, Ben Powney, Alan Wise, Steven Rees and Graeme Milligan
Molecular Pharmacology May 1, 2007, 71 (5) 1349-1359; DOI: https://doi.org/10.1124/mol.106.032722
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Differential Drug Effects on Homo/Heteromeric hERG Channels
  • ACKR3 Senses CXCR4 Activation Through GRK Phosphorylation
  • Analgesic Effects and Mechanisms of Licochalcones
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics